Geode Capital Management LLC Grows Stock Holdings in Teleflex Incorporated $TFX

Geode Capital Management LLC grew its position in Teleflex Incorporated (NYSE:TFX) by 10.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 985,684 shares of the medical technology company’s stock after buying an additional 94,679 shares during the quarter. Geode Capital Management LLC’s holdings in Teleflex were worth $120,312,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also recently modified their holdings of the company. Banque Cantonale Vaudoise lifted its stake in Teleflex by 82.5% during the 4th quarter. Banque Cantonale Vaudoise now owns 250 shares of the medical technology company’s stock worth $31,000 after acquiring an additional 113 shares in the last quarter. Hantz Financial Services Inc. increased its stake in Teleflex by 248.8% during the third quarter. Hantz Financial Services Inc. now owns 279 shares of the medical technology company’s stock worth $34,000 after purchasing an additional 199 shares during the period. Mirae Asset Global Investments Co. Ltd. purchased a new stake in Teleflex during the third quarter worth about $35,000. V Square Quantitative Management LLC purchased a new stake in Teleflex during the fourth quarter worth about $37,000. Finally, Sound Income Strategies LLC purchased a new stake in Teleflex during the fourth quarter worth about $45,000. Hedge funds and other institutional investors own 95.62% of the company’s stock.

Teleflex Stock Down 1.7%

Shares of NYSE:TFX opened at $129.90 on Friday. Teleflex Incorporated has a fifty-two week low of $100.18 and a fifty-two week high of $139.67. The firm’s 50 day moving average price is $127.08 and its 200 day moving average price is $118.04. The company has a quick ratio of 2.03, a current ratio of 2.55 and a debt-to-equity ratio of 0.82. The stock has a market cap of $5.75 billion, a price-to-earnings ratio of -5.70, a price-to-earnings-growth ratio of 0.98 and a beta of 0.82.

Teleflex (NYSE:TFX) last announced its quarterly earnings data on Thursday, May 7th. The medical technology company reported $1.39 EPS for the quarter, beating analysts’ consensus estimates of $1.21 by $0.18. Teleflex had a negative net margin of 35.88% and a positive return on equity of 13.29%. The company had revenue of $548.30 million for the quarter, compared to the consensus estimate of $536.91 million. During the same period in the prior year, the firm posted $1.44 EPS. The company’s quarterly revenue was up 32.3% compared to the same quarter last year. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. As a group, equities research analysts predict that Teleflex Incorporated will post 6.7 earnings per share for the current fiscal year.

Teleflex Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Monday, May 25th will be paid a $0.34 dividend. The ex-dividend date is Friday, May 22nd. This represents a $1.36 dividend on an annualized basis and a yield of 1.0%. Teleflex’s dividend payout ratio (DPR) is currently -5.96%.

Wall Street Analyst Weigh In

Several research analysts have recently commented on TFX shares. Weiss Ratings reissued a “sell (d)” rating on shares of Teleflex in a research note on Friday, March 27th. Royal Bank Of Canada raised shares of Teleflex from a “sector perform” rating to an “outperform” rating and upped their target price for the stock from $135.00 to $155.00 in a research note on Friday, May 8th. Zacks Research raised shares of Teleflex from a “strong sell” rating to a “hold” rating in a research report on Tuesday, April 28th. Needham & Company LLC boosted their price target on shares of Teleflex from $138.00 to $147.00 and gave the stock a “buy” rating in a research note on Thursday, February 26th. Finally, Raymond James Financial reaffirmed an “outperform” rating and set a $150.00 price objective on shares of Teleflex in a research report on Friday, May 8th. Three equities research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company has an average rating of “Hold” and an average price target of $144.00.

Teleflex Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.